Provided by Tiger Fintech (Singapore) Pte. Ltd.

AEON Biopharma

1.10
-0.3000-21.43%
Post-market: 1.09-0.0100-0.91%19:53 EDT
Volume:889.31K
Turnover:1.06M
Market Cap:12.81M
PE:-2.76
High:1.41
Open:1.34
Low:1.03
Close:1.40
52wk High:79.92
52wk Low:0.3750
Shares:11.64M
Float Shares:8.20M
Volume Ratio:1.28
T/O Rate:10.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3985
EPS(LYR):77.74
ROE:--
ROA:-129.01%
PB:-0.81
PE(LYR):0.01

Loading ...

Company Profile

Company Name:
AEON Biopharma
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
5
Office Location:
5 Park Plaza,Suite 1750,Irvine,California,United States
Zip Code:
92614
Fax:
- -
Introduction:
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.